Sequential designs for ordinal phase I clinical trials.
暂无分享,去创建一个
[1] Sequential Designs for Logistic Phase I Clinical Trials , 2006, Journal of biopharmaceutical statistics.
[2] M. Silvapulle,et al. Existence of Maximum Likelihood Estimates in Regression Models for Grouped and Ungrouped data , 1986 .
[3] J. Kiefer,et al. The Equivalence of Two Extremum Problems , 1960, Canadian Journal of Mathematics.
[4] C. F. Wu,et al. Efficient Sequential Designs with Binary Data , 1985 .
[5] Michael Woodroofe,et al. Isotonic smoothing splines under sequential designs , 1994 .
[6] L. Haines,et al. Bayesian Optimal Designs for Phase I Clinical Trials , 2003, Biometrics.
[7] V. Fedorov,et al. Adaptive designs for dose-finding based on efficacy–toxicity response , 2006 .
[8] E. Eisenhauer,et al. Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Nancy Flournoy,et al. Quantile estimation following non-parametric phase I clinical trials with ordinal response. , 2004, Statistics in medicine.
[10] J Whitehead,et al. Bayesian decision procedures based on logistic regression models for dose-finding studies. , 1998, Journal of biopharmaceutical statistics.
[11] Richard A. Lockhart. Editor's report/rapport du rédacteur en chef , 2003 .
[12] S Zacks,et al. Cancer phase I clinical trials: efficient dose escalation with overdose control. , 1998, Statistics in medicine.
[13] L. J. Wei,et al. Statistical Inference with Data-Dependent Treatment Allocation Rules , 1990 .
[14] William F. Rosenberger,et al. Optimal design for the proportional odds model , 2003 .
[15] R Simon,et al. Accelerated titration designs for phase I clinical trials in oncology. , 1997, Journal of the National Cancer Institute.